Royalty Pharma
RPRX
#1203
Rank
S$20.96 B
Marketcap
$35.58
Share price
0.11%
Change (1 day)
-1.92%
Change (1 year)

Royalty Pharma (RPRX) - Cash on Hand

Cash on Hand as of September 2024 : S$2.37 Billion

According to Royalty Pharma's latest financial reports the company has S$2.37 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Royalty Pharma - Cash on Hand chart (from 2019 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31S$1.62 B-49.94%
2022-12-31S$3.25 B-14.12%
2021-12-31S$3.78 B8.14%
2020-12-31S$3.50 B227.72%
2019-12-31S$1.06 B-67.19%
2018-12-31S$3.25 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
S$0.33 B-86.00%๐Ÿ‡บ๐Ÿ‡ธ USA
S$10.48 B 341.42%๐Ÿ‡บ๐Ÿ‡ธ USA
S$4.73 B 99.42%๐Ÿ‡บ๐Ÿ‡ธ USA